Recombinant human tumor necrosis factor: Began Phase I trial

Synergen Inc. (SYGN), Boulder, Colo. Product: Recombinant human tumor necrosis factor (TNF) binding protein, two copies of the receptor for TNF that are crosslinked with polyethylene glycol Indicatio...